Skip to main content
Innovation in Aging logoLink to Innovation in Aging
. 2017 Jun 30;1(Suppl 1):1383. doi: 10.1093/geroni/igx004.5089

BONE QUALITY MEASURED BY HR-PQCT IS NOT COMPROMISED IN TYPE 2 DIABETES—THE MAASTRICHT STUDY

EA deWaard 1,8, JJ de Jong 1,8, HH Savelberg 2,8, TA van Geel 3,4, PP Geusens 5,6,4, A Koster 7,4, JP van den Bergh 5,9,8
PMCID: PMC6183559

Abstract

Patients with type 2 diabetes mellitus (T2DM) are thought to have an increased fracture risk. Decreased bone quality could contribute to this increased risk. In this cross-sectional study of 306 participants from The Maastricht Study, we compared volumetric bone mineral density (vBMD), microarchitecture and strength at the distal radius in participants with T2DM (N=60, median HbA1c 6.9%, median diabetes duration 8.8 years) and with normal glucose metabolism (NGM, N=246) using high-resolution peripheral quantitative computed tomography. Unadjusted analyses showed increased cortical porosity (p<0.001) and pore volume (p<0.001) in T2DM compared to NGM. However, after adjustment for age, sex and BMI, the associations between T2DM and cortical porosity and pore volume were no longer significant (p>0.05). vBMD, trabecular microarchitecture and bone strength were not significantly different between both groups in both unadjusted and adjusted analyses (p>0.05). Concluding, in this group of relatively well-treated T2DM participants bone quality may not be compromised.


Articles from Innovation in Aging are provided here courtesy of Oxford University Press

RESOURCES